Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue

Gian Luca Erre; Arduino Aleksander Mangoni

doi:10.7573/DIC.2020-12-1

Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue

Gian Luca Erre, Arduino Aleksander Mangoni

College of Medicine and Public Health

Research output: Contribution to journal › Editorial

29 Downloads (Pure)

Abstract

This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.

Original language	English
Article number	10
Number of pages	3
Journal	Drugs in Context
Volume	10
DOIs	https://doi.org/10.7573/DIC.2020-12-1
Publication status	Published - Jan 2021

Keywords

Connective tissue diseases
Cyclophosphamide
Interstitial lung diseases
Mycophenolate
Nintedanib
Pierfenidone
Rituximab

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.7573/DIC.2020-12-1Licence: CC BY-NC-ND

Published versionFinal published version, 202 KBLicence: CC BY-NC-ND

Cite this

@article{4c64e2dcb579477a989886394b333f9e,

title = "Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue ",

abstract = "This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.",

keywords = "Connective tissue diseases, Cyclophosphamide, Interstitial lung diseases, Mycophenolate, Nintedanib, Pierfenidone, Rituximab",

author = "Erre, {Gian Luca} and Mangoni, {Arduino Aleksander}",

year = "2021",

month = jan,

doi = "10.7573/DIC.2020-12-1",

language = "English",

volume = "10",

journal = "Drugs in Context",

issn = "1745-1981",

publisher = "Bioexcel Publishing LTD",

}

TY - JOUR

T1 - Current therapeutic strategies in connective tissue disease-related interstitial lung disease

T2 - introduction to the special issue

AU - Erre, Gian Luca

AU - Mangoni, Arduino Aleksander

PY - 2021/1

Y1 - 2021/1

N2 - This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.

AB - This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.

KW - Connective tissue diseases

KW - Cyclophosphamide

KW - Interstitial lung diseases

KW - Mycophenolate

KW - Nintedanib

KW - Pierfenidone

KW - Rituximab

UR - http://www.scopus.com/inward/record.url?scp=85100655732&partnerID=8YFLogxK

U2 - 10.7573/DIC.2020-12-1

DO - 10.7573/DIC.2020-12-1

M3 - Editorial

AN - SCOPUS:85100655732

SN - 1745-1981

VL - 10

JO - Drugs in Context

JF - Drugs in Context

M1 - 10

ER -

Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this